| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.57 | 0.01 | 0.57 | Calpain 2 inhibitor | 0.305 0.111 CID_91649 | ||
| 0.503 | 0.074 | 0.503 | Transcription factor inhibitor | 0.224 0.206 CID_91649 | ||
| 0.444 | 0.054 | 0.456 | Calcium channel L-type activator | 0.456 0.047 CID_91649 | CID_91649 | |
| 0.36 | 0.005 | 0.623 | Androgen antagonist | 0.623 0.003 CID_91649 | CID_91649 | |
| 0.43 | 0.076 | 0.43 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.391 0.109 CID_91649 | ||
| 0.417 | 0.067 | 0.417 | Histamine release inhibitor | 0.23 0.172 CID_91649 | ||
| 0.327 | 0.041 | 0.327 | Transcription factor STAT3 inhibitor | 0.18 0.164 CID_91649 | ||
| 0.275 | 0.005 | 0.43 | Potassium channel activator | 0.43 0.003 CID_91649 | CID_91649 | |
| 0.297 | 0.031 | 0.297 | Calpain inhibitor | 0.167 0.153 CID_91649 | ||
| 0.309 | 0.051 | 0.309 | Transcription factor STAT inhibitor | |||
| 0.285 | 0.027 | 0.285 | Neuropeptide Y2 antagonist | 0.227 0.08 CID_91649 | ||
| 0.384 | 0.126 | 0.384 | DNA polymerase beta inhibitor | |||
| 0.381 | 0.123 | 0.498 | Caspase 9 stimulant | 0.498 0.06 CID_91649 | CID_91649 | |
| 0.255 | 0.008 | 0.255 | Catalase inhibitor | 0.181 0.019 CID_91649 | ||
| 0.307 | 0.069 | 0.307 | Interleukin 2 agonist | 0.273 0.095 CID_91649 | ||
| 0.303 | 0.078 | 0.303 | 12-Lipoxygenase inhibitor | 0.202 0.15 CID_91649 | ||
| 0.226 | 0.005 | 0.242 | Prostaglandin-E synthase inhibitor | 0.242 0.005 CID_91649 | CID_91649 | |
| 0.223 | 0.004 | 0.223 | NMDA receptor agonist | 0.192 0.005 CID_91649 | ||
| 0.251 | 0.032 | 0.251 | Amyloid beta precursor protein antagonist | |||
| 0.335 | 0.129 | 0.335 | 5 Hydroxytryptamine release inhibitor | 0.29 0.177 CID_91649 | ||
| 0.344 | 0.139 | 0.344 | Alpha-glucosidase inhibitor | 0.274 0.174 CID_91649 | ||
| 0.344 | 0.14 | 0.344 | DNA directed DNA polymerase inhibitor | |||
| 0.232 | 0.035 | 0.232 | 3C-like protease (Human coronavirus) inhibitor | 0.147 0.106 CID_91649 | ||
| 0.198 | 0.003 | 0.198 | NMDA receptor glycine site agonist | 0.189 0.003 CID_91649 | ||
| 0.297 | 0.104 | 0.297 | Thioredoxin glutathione reductase inhibitor | |||
| 0.314 | 0.129 | 0.314 | Beta lactamase inhibitor | |||
| 0.196 | 0.013 | 0.196 | Sphingosine 1-phosphate receptor 5 antagonist | 0.177 0.026 CID_91649 | ||
| 0.228 | 0.051 | 0.228 | Nitric-oxide synthase stimulant | 0.2 0.089 CID_91649 | ||
| 0.214 | 0.039 | 0.214 | Succinate dehydrogenase inhibitor | 0.193 0.054 CID_91649 | ||
| 0.179 | 0.005 | 0.302 | Androgen agonist | 0.302 0.003 CID_91649 | CID_91649 | |
| 0.265 | 0.094 | 0.265 | Streptokinase A inhibitor | |||
| 0.272 | 0.104 | 0.272 | Thyroid hormone beta antagonist | |||
| 0.279 | 0.113 | 0.325 | Calcium channel activator | 0.325 0.068 CID_91649 | CID_91649 | |
| 0.273 | 0.109 | 0.273 | Thyroid hormone antagonist | |||
| 0.237 | 0.082 | 0.237 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.216 0.091 CID_91649 | ||
| 0.186 | 0.038 | 0.186 | M17 leucyl aminopeptidase inhibitor | 0.122 0.076 CID_91649 | ||
| 0.189 | 0.044 | 0.189 | Thiol protease inhibitor | 0.123 0.11 CID_91649 | ||
| 0.145 | 0.003 | 0.145 | Dihydroorotate oxidase inhibitor | 0.131 0.003 CID_91649 | ||
| 0.179 | 0.037 | 0.229 | CF transmembrane conductance regulator agonist | 0.229 0.01 CID_91649 | CID_91649 | |
| 0.139 | 0.005 | 0.139 | Glutamate (mGluR group III) agonist | 0.048 0.025 CID_91649 | ||
| 0.225 | 0.093 | 0.225 | Superoxide dismutase inhibitor | 0.2 0.117 CID_91649 | ||
| 0.16 | 0.029 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | 0.146 0.047 CID_91649 | ||
| 0.156 | 0.026 | 0.159 | Potassium channel (Ca-activated) activator | 0.159 0.025 CID_91649 | CID_91649 | |
| 0.231 | 0.103 | 0.261 | Gastrin inhibitor | 0.261 0.067 CID_91649 | CID_91649 | |
| 0.156 | 0.028 | 0.156 | Sphingosine 1-phosphate receptor 4 antagonist | 0.149 0.035 CID_91649 | ||
| 0.151 | 0.023 | 0.151 | Urease inhibitor | 0.148 0.024 CID_91649 | ||
| 0.141 | 0.016 | 0.141 | Potassium channel (Voltage-sensitive) activator | 0.127 0.026 CID_91649 | ||
| 0.15 | 0.027 | 0.15 | CDK3/cyclin E inhibitor | 0.132 0.041 CID_91649 | ||
| 0.212 | 0.096 | 0.212 | Aryl hydrocarbon receptor agonist | |||
| 0.156 | 0.042 | 0.156 | Cathepsin H inhibitor | |||
| 0.141 | 0.035 | 0.141 | Caspase 3 inhibitor | 0.115 0.068 CID_91649 | ||
| 0.171 | 0.066 | 0.171 | Death-associated protein kinase 2 inhibitor | 0.162 0.082 CID_91649 | ||
| 0.136 | 0.034 | 0.161 | UDP-glucose 4-epimerase inhibitor | 0.161 0.025 CID_91649 | CID_91649 | |
| 0.209 | 0.113 | 0.259 | Interleukin agonist | 0.259 0.072 CID_91649 | CID_91649 | |
| 0.184 | 0.089 | 0.184 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.097 | 0.004 | 0.097 | NMDA receptor glycine site antagonist | 0.083 0.004 CID_91649 | ||
| 0.137 | 0.044 | 0.137 | Aminopeptidase B inhibitor | 0.089 0.073 CID_91649 | ||
| 0.142 | 0.052 | 0.142 | Death-associated protein kinase 1 inhibitor | 0.123 0.102 CID_91649 | ||
| 0.101 | 0.011 | 0.101 | Dihydroorotate dehydrogenase inhibitor | 0.074 0.02 CID_91649 | ||
| 0.115 | 0.026 | 0.115 | Glutathione S-transferase inhibitor | 0.113 0.027 CID_91649 | ||
| 0.127 | 0.041 | 0.127 | Falcipain inhibitor | |||
| 0.125 | 0.04 | 0.125 | Falcipain 2 inhibitor | |||
| 0.118 | 0.033 | 0.212 | Triose-phosphate isomerase inhibitor | 0.212 0.01 CID_91649 | CID_91649 | |
| 0.096 | 0.011 | 0.096 | Exportin-1 inhibitor | 0.068 0.048 CID_91649 | ||
| 0.165 | 0.084 | 0.165 | LIM domain kinase 1 inhibitor | |||
| 0.085 | 0.005 | 0.085 | Glutamate (mGluR4) agonist | 0.035 0.022 CID_91649 | ||
| 0.086 | 0.006 | 0.099 | Potassium channel (Inward rectifier) activator | 0.099 0.005 CID_91649 | CID_91649 | |
| 0.088 | 0.009 | 0.088 | Kainate receptor antagonist | 0.066 0.013 CID_91649 | ||
| 0.083 | 0.006 | 0.096 | Potassium channel (ATP-sensitive) activator | 0.096 0.005 CID_91649 | CID_91649 | |
| 0.142 | 0.068 | 0.142 | Pregnane X receptor agonist | 0.141 0.071 CID_91649 | ||
| 0.086 | 0.013 | 0.086 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.107 | 0.035 | 0.107 | Bcr-Abl kinase inhibitor | 0.1 0.041 CID_91649 | ||
| 0.096 | 0.024 | 0.096 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.058 CID_91649 | ||
| 0.096 | 0.025 | 0.103 | Potassium channel large-conductance Ca-activated activator | 0.103 0.023 CID_91649 | CID_91649 | |
| 0.113 | 0.043 | 0.12 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.12 0.039 CID_91649 | CID_91649 | |
| 0.074 | 0.004 | 0.074 | Glutamate (mGluR8) agonist | 0.074 0.004 CID_91649 | ||
| 0.103 | 0.034 | 0.103 | Vanilloid antagonist | |||
| 0.138 | 0.07 | 0.138 | Calcium channel blocker | |||
| 0.215 | 0.147 | 0.215 | Prostaglandin dehydrogenase inhibitor | |||
| 0.115 | 0.048 | 0.13 | Adenylate kinase inhibitor | 0.13 0.036 CID_91649 | CID_91649 | |
| 0.156 | 0.091 | 0.156 | ATPase inhibitor | 0.14 0.119 CID_91649 | ||
| 0.09 | 0.031 | 0.09 | Vanilloid 1 antagonist | |||
| 0.117 | 0.06 | 0.117 | Calcium channel (voltage-sensitive) blocker | |||
| 0.067 | 0.011 | 0.067 | Collagenase inhibitor | 0.05 0.033 CID_91649 | ||
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | 0.064 0.039 CID_91649 | ||
| 0.137 | 0.086 | 0.137 | Neuropeptide Y1 antagonist | |||
| 0.098 | 0.049 | 0.098 | Calcium antagonist | |||
| 0.059 | 0.011 | 0.059 | Delayed rectifier potassium channel activator | 0.047 0.018 CID_91649 | ||
| 0.059 | 0.011 | 0.059 | Potassium channel KCNQ activator | 0.047 0.018 CID_91649 | ||
| 0.09 | 0.045 | 0.09 | D-Ala-D-Ala ligase inhibitor | 0.083 0.059 CID_91649 | ||
| 0.149 | 0.105 | 0.149 | Neurotensin receptor agonist | |||
| 0.088 | 0.044 | 0.089 | Thioredoxin reductase inhibitor | 0.089 0.043 CID_91649 | CID_91649 | |
| 0.058 | 0.015 | 0.058 | Glutamate (mGluR4) antagonist | 0.046 0.025 CID_91649 | ||
| 0.101 | 0.059 | 0.124 | Creatine kinase inhibitor | 0.124 0.038 CID_91649 | CID_91649 | |
| 0.098 | 0.057 | 0.12 | Interleukin 12 antagonist | 0.12 0.029 CID_91649 | CID_91649 | |
| 0.052 | 0.012 | 0.06 | Potassium channel Kv1.1 blocker | 0.06 0.009 CID_91649 | CID_91649 | |
| 0.063 | 0.024 | 0.074 | Glycine transporter 2 inhibitor | 0.074 0.019 CID_91649 | CID_91649 | |
| 0.07 | 0.032 | 0.094 | Biliverdin reductase inhibitor | 0.094 0.02 CID_91649 | CID_91649 | |
| 0.053 | 0.015 | 0.055 | Nerve growth factor antagonist | 0.055 0.013 CID_91649 | CID_91649 | |
| 0.099 | 0.063 | 0.147 | Anabolic | 0.147 0.02 CID_91649 | CID_91649 | |
| 0.078 | 0.042 | 0.078 | Calcium channel L-type blocker | |||
| 0.202 | 0.167 | 0.206 | Transcription factor NF kappa B inhibitor | 0.206 0.163 CID_91649 | CID_91649 | |
| 0.078 | 0.044 | 0.078 | Epoxide hydrolase inhibitor | |||
| 0.048 | 0.015 | 0.048 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.039 | 0.007 | 0.039 | Kainate receptor 1 antagonist | 0.023 0.013 CID_91649 | ||
| 0.048 | 0.017 | 0.048 | Kainate receptor 2 antagonist | |||
| 0.033 | 0.004 | 0.085 | Progesterone receptor B antagonist | 0.085 0.002 CID_91649 | CID_91649 | |
| 0.041 | 0.013 | 0.041 | Catechol O-methyltransferase inhibitor | 0.038 0.015 CID_91649 | ||
| 0.049 | 0.021 | 0.136 | CDK5/p25 inhibitor | 0.136 0.005 CID_91649 | CID_91649 | |
| 0.055 | 0.027 | 0.058 | Plasminogen activator inhibitor antagonist | 0.058 0.025 CID_91649 | CID_91649 | |
| 0.062 | 0.035 | 0.089 | Argininosuccinate synthase inhibitor | 0.089 0.022 CID_91649 | CID_91649 | |
| 0.076 | 0.05 | 0.076 | Vanilloid 4 agonist | |||
| 0.195 | 0.169 | 0.242 | Cholesterol antagonist | 0.242 0.131 CID_91649 | CID_91649 | |
| 0.122 | 0.097 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.119 0.103 CID_91649 | ||
| 0.074 | 0.049 | 0.074 | Metalloproteinase-9 inhibitor | |||
| 0.066 | 0.042 | 0.066 | Neuraminidase (influenza) inhibitor | |||
| 0.097 | 0.074 | 0.125 | Ferrochelatase inhibitor | 0.125 0.05 CID_91649 | CID_91649 | |
| 0.132 | 0.108 | 0.132 | Heat shock protein 90 alpha antagonist | |||
| 0.104 | 0.081 | 0.104 | TRPA1 agonist | |||
| 0.062 | 0.039 | 0.062 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.11 | 0.088 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.148 0.056 CID_91649 | CID_91649 | |
| 0.083 | 0.061 | 0.083 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.116 | 0.096 | 0.116 | Vanilloid 1 agonist | 0.116 0.099 CID_91649 | ||
| 0.064 | 0.044 | 0.072 | Transcription factor RelA inhibitor | 0.072 0.027 CID_91649 | CID_91649 | |
| 0.12 | 0.1 | 0.12 | Cytidine deaminase inhibitor | |||
| 0.028 | 0.009 | 0.028 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.026 | 0.007 | 0.026 | Factor XIII inhibitor | 0.025 0.007 CID_91649 | ||
| 0.072 | 0.053 | 0.072 | Nav1.8 sodium channel blocker | |||
| 0.186 | 0.168 | 0.186 | MAP kinase kinase 3 inhibitor | |||
| 0.092 | 0.074 | 0.092 | Nitric-oxide synthase inhibitor | |||
| 0.035 | 0.017 | 0.035 | AMPA 1 receptor antagonist | 0.03 0.02 CID_91649 | ||
| 0.098 | 0.081 | 0.098 | DOPA decarboxylase inhibitor | |||
| 0.059 | 0.042 | 0.059 | Ca(v)3.2 blocker | |||
| 0.023 | 0.006 | 0.052 | Potassium channel (Inward rectifier) 11 blocker | 0.052 0.002 CID_91649 | CID_91649 | |
| 0.075 | 0.058 | 0.075 | Metalloproteinase-2 inhibitor | |||
| 0.058 | 0.041 | 0.058 | Cathepsin L inhibitor | |||
| 0.044 | 0.029 | 0.044 | Carbonic anhydrase IV inhibitor | |||
| 0.026 | 0.011 | 0.026 | Kainate receptor 5 antagonist | 0.025 0.012 CID_91649 | ||
| 0.059 | 0.044 | 0.059 | Neuraminidase inhibitor | |||
| 0.08 | 0.065 | 0.08 | CC chemokine 5 receptor agonist | |||
| 0.085 | 0.071 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.101 | 0.087 | 0.101 | Interleukin 2 antagonist | |||
| 0.044 | 0.031 | 0.044 | Dihydroorotase inhibitor | |||
| 0.027 | 0.015 | 0.027 | Kainate receptor 4 antagonist | 0.025 0.017 CID_91649 | ||
| 0.032 | 0.022 | 0.032 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.06 | 0.051 | 0.06 | Neutrophil collagenase inhibitor | |||
| 0.055 | 0.046 | 0.055 | Botulinum neurotoxin type A inhibitor | |||
| 0.037 | 0.028 | 0.037 | TRPM8 blocker | 0.035 0.031 CID_91649 | ||
| 0.068 | 0.059 | 0.085 | Glutamate dehydrogenase inhibitor | 0.085 0.04 CID_91649 | CID_91649 | |
| 0.078 | 0.069 | 0.106 | NMDA receptor antagonist | 0.106 0.044 CID_91649 | CID_91649 | |
| 0.045 | 0.036 | 0.045 | AMPA receptor antagonist | |||
| 0.015 | 0.006 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.11 | 0.101 | 0.13 | Interleukin 4 antagonist | 0.13 0.071 CID_91649 | CID_91649 | |
| 0.115 | 0.107 | 0.145 | Cell wall synthesis inhibitor | 0.145 0.07 CID_91649 | CID_91649 | |
| 0.02 | 0.013 | 0.023 | 5-Alpha-reductase 2 inhibitor | 0.023 0.011 CID_91649 | CID_91649 | |
| 0.034 | 0.027 | 0.034 | Nicotinic acid receptor agonist | |||
| 0.059 | 0.052 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.047 | 0.041 | 0.048 | Lysophosphatidic acid 3 receptor antagonist | 0.048 0.039 CID_91649 | CID_91649 | |
| 0.04 | 0.035 | 0.041 | NMDA receptor subunit 3B antagonist | 0.041 0.034 CID_91649 | CID_91649 | |
| 0.029 | 0.024 | 0.029 | Cyclophilin A inhibitor | 0.028 0.027 CID_91649 | ||
| 0.069 | 0.064 | 0.079 | GABA aminotransferase inhibitor | 0.079 0.048 CID_91649 | CID_91649 | |
| 0.041 | 0.037 | 0.041 | Glutamate (mGluR group III) antagonist | |||
| 0.025 | 0.022 | 0.025 | NMDA 2D receptor antagonist | 0.025 0.022 CID_91649 | ||
| 0.047 | 0.044 | 0.063 | CD45 antagonist | 0.063 0.019 CID_91649 | CID_91649 | |
| 0.18 | 0.177 | 0.183 | Tyrosine 3 hydroxylase inhibitor | 0.183 0.17 CID_91649 | CID_91649 | |
| 0.028 | 0.026 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.048 | 0.046 | 0.048 | Acetyl-CoA transferase inhibitor | |||
| 0.099 | 0.097 | 0.099 | Calcium channel N-type blocker | |||
| 0.011 | 0.01 | 0.012 | Glutamate (mGluR6) agonist | 0.012 0.009 CID_91649 | CID_91649 | |
| 0.046 | 0.045 | 0.046 | Neuropeptide agonist | |||
| 0.015 | 0.014 | 0.015 | Kainate receptor 3 antagonist | |||
| 0.104 | 0.106 | 0.113 | NADPH oxidase inhibitor | 0.113 0.093 CID_91649 | CID_91649 | |
| 0.145 | 0.146 | 0.177 | Neurotrophic factor enhancer | 0.177 0.102 CID_91649 | CID_91649 | |
| 0.039 | 0.041 | 0.046 | AICAR transformylase inhibitor | 0.046 0.027 CID_91649 | CID_91649 | |
| 0.046 | 0.05 | 0.069 | Alcohol oxidase inhibitor | 0.069 0.029 CID_91649 | CID_91649 | |
| 0.059 | 0.069 | 0.085 | Porphobilinogen synthase inhibitor | 0.085 0.044 CID_91649 | CID_91649 | |
| 0.067 | 0.081 | 0.08 | GABA B receptor agonist | 0.08 0.042 CID_91649 | CID_91649 | |
| 0.049 | 0.066 | 0.062 | Purinergic P2X1 antagonist | 0.062 0.041 CID_91649 | CID_91649 | |
| 0.023 | 0.04 | 0.069 | Progesterone antagonist | 0.069 0.012 CID_91649 | CID_91649 | |
| 0.063 | 0.091 | 0.081 | Glycine receptor antagonist | 0.081 0.055 CID_91649 | CID_91649 | |
| 0.12 | 0.15 | 0.172 | Anesthetic general | 0.172 0.092 CID_91649 | CID_91649 | |
| 0.124 | 0.158 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.122 CID_91649 | CID_91649 | |
| 0.044 | 0.079 | 0.075 | Phosphofructokinase-1 inhibitor | 0.075 0.044 CID_91649 | CID_91649 | |
| 0.041 | 0.076 | 0.064 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.064 0.035 CID_91649 | CID_91649 | |
| 0.045 | 0.091 | 0.075 | Histidine decarboxylase inhibitor | 0.075 0.046 CID_91649 | CID_91649 | |
| 0.066 | 0.134 | 0.091 | ABCA1 expression enhancer | 0.091 0.063 CID_91649 | CID_91649 | |
| 0.098 | 0.168 | 0.133 | Papain-like protease (SARS coronavirus) inhibitor | 0.133 0.055 CID_91649 | CID_91649 | |
| 0.143 | 0.216 | 0.189 | Peptidyltransferase inhibitor | 0.189 0.114 CID_91649 | CID_91649 | |
| 0.078 | 0.156 | 0.105 | Factor V inhibitor | 0.105 0.059 CID_91649 | CID_91649 | |
| 0.133 | 0.231 | 0.167 | MAP kinase kinase 5 inhibitor | 0.167 0.093 CID_91649 | CID_91649 | |
| 0.05 | 0.16 | 0.064 | MDM2 inhibitor | 0.064 0.058 CID_91649 | CID_91649 | |
| 0.06 | 0.174 | 0.13 | AMP-activated protein kinase stimulant | 0.13 0.041 CID_91649 | CID_91649 | |
| 0.081 | 0.21 | 0.135 | Hexokinase inhibitor | 0.135 0.098 CID_91649 | CID_91649 | |
| 0.08 | 0.215 | 0.179 | Farnesoid X receptor antagonist | 0.179 0.03 CID_91649 | CID_91649 | |
| 0.032 | 0.181 | 0.068 | Potassium channel (ATP-sensitive) blocker | 0.068 0.044 CID_91649 | CID_91649 | |
| 0.058 | 0.221 | 0.108 | Cytokine production inhibitor | 0.108 0.102 CID_91649 | CID_91649 | |
| 0.014 | 0.188 | 0.047 | Liver X receptor agonist | 0.047 0.026 CID_91649 | CID_91649 | |
| 0.018 | 0.272 | 0.087 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.087 0.061 CID_91649 | CID_91649 | |
| 0.044 | 0.399 | 0.118 | Aurora-C kinase inhibitor | 0.118 0.111 CID_91649 | CID_91649 | |
| 0.008 | 0.475 | 0.048 | Mineralocorticoid receptor antagonist | 0.048 0.033 CID_91649 | CID_91649 | |
| 0.024 | 0.766 | 0.302 | Cyclophilin D inhibitor | 0.302 0.161 CID_91649 | CID_91649 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |